Logo image of NVST

ENVISTA HOLDINGS CORP (NVST) Stock Fundamental Analysis

NYSE:NVST - New York Stock Exchange, Inc. - US29415F1049 - Common Stock - Currency: USD

15.18  +0.16 (+1.07%)

After market: 15.18 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NVST. NVST was compared to 191 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of NVST get a neutral evaluation. Nothing too spectacular is happening here. NVST may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

NVST had positive earnings in the past year.
NVST had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NVST reported negative net income in multiple years.
NVST had a positive operating cash flow in each of the past 5 years.
NVST Yearly Net Income VS EBIT VS OCF VS FCFNVST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

NVST has a Return On Assets of -20.91%. This is comparable to the rest of the industry: NVST outperforms 50.26% of its industry peers.
NVST has a Return On Equity of -38.12%. This is comparable to the rest of the industry: NVST outperforms 54.45% of its industry peers.
NVST has a Return On Invested Capital of 2.76%. This is in the better half of the industry: NVST outperforms 72.25% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NVST is below the industry average of 7.68%.
Industry RankSector Rank
ROA -20.91%
ROE -38.12%
ROIC 2.76%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
NVST Yearly ROA, ROE, ROICNVST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Operating Margin of NVST (6.22%) is better than 73.82% of its industry peers.
In the last couple of years the Operating Margin of NVST has declined.
With a Gross Margin value of 55.43%, NVST perfoms like the industry average, outperforming 48.17% of the companies in the same industry.
In the last couple of years the Gross Margin of NVST has remained more or less at the same level.
Industry RankSector Rank
OM 6.22%
PM (TTM) N/A
GM 55.43%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
NVST Yearly Profit, Operating, Gross MarginsNVST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NVST is destroying value.
NVST has more shares outstanding than it did 1 year ago.
NVST has more shares outstanding than it did 5 years ago.
NVST has a worse debt/assets ratio than last year.
NVST Yearly Shares OutstandingNVST Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVST Yearly Total Debt VS Total AssetsNVST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.29, we must say that NVST is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.29, NVST perfoms like the industry average, outperforming 56.54% of the companies in the same industry.
NVST has a debt to FCF ratio of 4.61. This is a neutral value as NVST would need 4.61 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.61, NVST belongs to the top of the industry, outperforming 82.72% of the companies in the same industry.
NVST has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
NVST's Debt to Equity ratio of 0.44 is in line compared to the rest of the industry. NVST outperforms 44.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.61
Altman-Z 1.29
ROIC/WACC0.34
WACC8.07%
NVST Yearly LT Debt VS Equity VS FCFNVST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

NVST has a Current Ratio of 2.04. This indicates that NVST is financially healthy and has no problem in meeting its short term obligations.
NVST's Current ratio of 2.04 is on the low side compared to the rest of the industry. NVST is outperformed by 62.83% of its industry peers.
NVST has a Quick Ratio of 1.76. This is a normal value and indicates that NVST is financially healthy and should not expect problems in meeting its short term obligations.
NVST's Quick ratio of 1.76 is in line compared to the rest of the industry. NVST outperforms 46.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.76
NVST Yearly Current Assets VS Current LiabilitesNVST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

NVST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.29%.
The earnings per share for NVST have been decreasing by -28.29% on average. This is quite bad
NVST shows a decrease in Revenue. In the last year, the revenue decreased by -2.18%.
The Revenue has been growing slightly by 1.90% on average over the past years.
EPS 1Y (TTM)-52.29%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%-17.24%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%1.13%

3.2 Future

Based on estimates for the next years, NVST will show a very strong growth in Earnings Per Share. The EPS will grow by 33.46% on average per year.
Based on estimates for the next years, NVST will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y38.52%
EPS Next 2Y26.34%
EPS Next 3Y21.25%
EPS Next 5Y33.46%
Revenue Next Year0.63%
Revenue Next 2Y1.86%
Revenue Next 3Y2.37%
Revenue Next 5Y7.74%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVST Yearly Revenue VS EstimatesNVST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
NVST Yearly EPS VS EstimatesNVST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.79 indicates a rather expensive valuation of NVST.
Based on the Price/Earnings ratio, NVST is valued cheaply inside the industry as 81.15% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of NVST to the average of the S&P500 Index (28.29), we can say NVST is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 15.01, the valuation of NVST can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NVST indicates a rather cheap valuation: NVST is cheaper than 84.29% of the companies listed in the same industry.
NVST's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.32.
Industry RankSector Rank
PE 20.79
Fwd PE 15.01
NVST Price Earnings VS Forward Price EarningsNVST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NVST is valued cheaper than 87.96% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NVST is valued cheaply inside the industry as 97.38% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.64
EV/EBITDA 10.53
NVST Per share dataNVST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

NVST's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NVST's earnings are expected to grow with 21.25% in the coming years.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y26.34%
EPS Next 3Y21.25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NVST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVISTA HOLDINGS CORP

NYSE:NVST (4/17/2025, 8:04:00 PM)

After market: 15.18 0 (0%)

15.18

+0.16 (+1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-01 2025-05-01/amc
Inst Owners114.26%
Inst Owner Change-0.1%
Ins Owners0.63%
Ins Owner Change4.26%
Market Cap2.61B
Analysts71
Price Target21.98 (44.8%)
Short Float %5.02%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.61%
Min EPS beat(2)7.34%
Max EPS beat(2)29.88%
EPS beat(4)2
Avg EPS beat(4)-10.45%
Min EPS beat(4)-59.95%
Max EPS beat(4)29.88%
EPS beat(8)3
Avg EPS beat(8)-9.17%
EPS beat(12)6
Avg EPS beat(12)-5.27%
EPS beat(16)10
Avg EPS beat(16)2.19%
Revenue beat(2)0
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)-0.18%
Revenue beat(4)0
Avg Revenue beat(4)-2.18%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)-0.18%
Revenue beat(8)0
Avg Revenue beat(8)-2.34%
Revenue beat(12)0
Avg Revenue beat(12)-2.19%
Revenue beat(16)1
Avg Revenue beat(16)-3.31%
PT rev (1m)-5.95%
PT rev (3m)0.99%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)-17.68%
EPS NY rev (1m)-0.39%
EPS NY rev (3m)-12.68%
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)-3.95%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-1.95%
Valuation
Industry RankSector Rank
PE 20.79
Fwd PE 15.01
P/S 1.04
P/FCF 8.64
P/OCF 7.77
P/B 0.89
P/tB 113.65
EV/EBITDA 10.53
EPS(TTM)0.73
EY4.81%
EPS(NY)1.01
Fwd EY6.66%
FCF(TTM)1.76
FCFY11.58%
OCF(TTM)1.95
OCFY12.87%
SpS14.58
BVpS17.04
TBVpS0.13
PEG (NY)0.54
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.91%
ROE -38.12%
ROCE 3.49%
ROIC 2.76%
ROICexc 3.62%
ROICexgc 25.12%
OM 6.22%
PM (TTM) N/A
GM 55.43%
FCFM 12.06%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
ROICexc(3y)4.97%
ROICexc(5y)5.02%
ROICexgc(3y)81.26%
ROICexgc(5y)N/A
ROCE(3y)5.28%
ROCE(5y)5.25%
ROICexcg growth 3Y-55.07%
ROICexcg growth 5Y-3.56%
ROICexc growth 3Y-21.01%
ROICexc growth 5Y-0.5%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.61
Debt/EBITDA 4.58
Cap/Depr 27.46%
Cap/Sales 1.35%
Interest Coverage 2.85
Cash Conversion 120.52%
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.76
Altman-Z 1.29
F-Score3
WACC8.07%
ROIC/WACC0.34
Cap/Depr(3y)41.77%
Cap/Depr(5y)41.11%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.29%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%-17.24%
EPS Next Y38.52%
EPS Next 2Y26.34%
EPS Next 3Y21.25%
EPS Next 5Y33.46%
Revenue 1Y (TTM)-2.18%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%1.13%
Revenue Next Year0.63%
Revenue Next 2Y1.86%
Revenue Next 3Y2.37%
Revenue Next 5Y7.74%
EBIT growth 1Y-51.95%
EBIT growth 3Y-26.9%
EBIT growth 5Y-8.72%
EBIT Next Year46.96%
EBIT Next 3Y19.61%
EBIT Next 5Y29.05%
FCF growth 1Y39.17%
FCF growth 3Y-0.46%
FCF growth 5Y-1.09%
OCF growth 1Y22.05%
OCF growth 3Y-2.37%
OCF growth 5Y-3.28%